首页> 外文期刊>The Journal of Urology >Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer.
【24h】

Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer.

机译:术中前哨淋巴结检测可改善浸润性膀胱癌的淋巴结分期。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We evaluated intraoperative SN detection in patients with invasive bladder cancer during radical cystectomy in conjunction with extended lymphadenectomy. MATERIALS AND METHODS: A total of 75 patients with invasive bladder cancer underwent radical cystectomy with extended lymphadenectomy. SNs were identified by preoperative lymphoscintigraphy, intraoperative dynamic lymphoscintigraphy and blue dye detection. An isotope (70 MBq (99m)Tc-nanocolloid) and Patent Blue(R) blue dye were injected peritumorally via a cystoscope. Excised lymph nodes were examined ex vivo using a handheld gamma probe. Identified SNs were evaluated by extended serial sectioning, hematoxylin and eosin staining, and immunohistochemistry. RESULTS: At lymphadenectomy an average of 40 nodes (range 8 to 67) were removed. Of 75 patients 32 (43%) were lymph node positive, of whom 13 (41%) had all lymph node metastases located only outside of the obturator spaces. An SN was identified in 65 of 75 patients (87%). In 7 patients an SNwas recognized when the nodal basins were assessed with the gamma probe after lymphadenectomy and cystectomy. Of the 32 lymph node positive cases 26 (81%) had a positive (metastatic) SN. Thus, the false-negative rate was 6 of 32 cases (19%). Five false-negative cases had macrometastases and/or perivesical metastases. In 9 patients (14%) the SN contained micrometastases (less than 2 mm), in 5 of whom the micrometastasis was the only metastatic deposit. CONCLUSIONS: SN detection is feasible in invasive bladder cancer, although the false- negative rate was 19% in this study. Extended serial sectioning and immunohistochemistry revealed micrometastases in SNs in 9 patients and radio guided surgery after the completion of lymphadenectomy identified SNs in an additional 7. We believe that the technique that we used in this study improved nodal staging in these 16 of 65 patients (25%).
机译:目的:我们评估了在根治性膀胱切除术与扩展的淋巴结切除术期间浸润性膀胱癌患者的术中SN检测。材料与方法:共有75例浸润性膀胱癌患者接受了根治性膀胱切除术和延长的淋巴结清扫术。通过术前淋巴闪烁显像,术中动态淋巴闪烁显像和蓝色染料检测来识别SN。同位素(70 MBq(99m)Tc-纳米胶体)和Patent Blue蓝染料通过膀胱镜经皮周注入。使用手持式伽马探针离体检查切除的淋巴结。通过扩展的连续切片,苏木精和曙红染色以及免疫组化评估鉴定出的SN。结果:在淋巴结清扫术中,平均去除了40个淋巴结(范围从8到67)。在75名患者中,有32名(43%)淋巴结阳性,其中13名(41%)的所有淋巴结转移仅位于闭孔间隙之外。 75例患者中有65例(87%)发现了SN。在7例患者中,当在淋巴结清扫术和膀胱切除术后用伽马探针评估结节盆时,SN被识别。在32例淋巴结阳性病例中,有26例(81%)的SN阳性(转移性)。因此,假阴性率为32例中的6例(19%)。五例假阴性病例发生了巨转移和/或镜下转移。在9例(14%)的SN中,微转移灶(小于2毫米),其中5例是微转移灶是唯一的转移性沉积物。结论:SN检测在浸润性膀胱癌中是可行的,尽管本研究的假阴性率为19%。扩展的连续切片和免疫组织化学结果显示9例患者的SN有微转移,淋巴结清扫术完成后在7例中发现了SN,我们进行了放射引导手术。我们相信,这项研究中使用的技术改善了这65例患者中的16例的淋巴结分期(25 %)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号